{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:32:57Z","timestamp":1792801977893,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi & Co., Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Antimicrobial resistance is considered one of the most dangerous threats to public health globally. In the last decade, several antimicrobial agents were developed for the treatment of infections with multidrug-resistant Gram-negative bacteria, especially carbapenem-resistant isolates. The aim of this study was to investigate the in vitro activity of the siderophore cephalosporin cefiderocol (FDC) and four comparator beta-lactam\u2013beta-lactamase-inhibitor combinations (ceftazidime\/avibactam, ceftolozane\/tazobactam, imipenem\/relebactam and meropenem\/vaborbactam) against 401 clinical isolates of Gram-negative pathogens collected in Germany between 2019 and 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Genetic determinants of resistance were investigated by PCR and\/or whole-genome sequencing. Furthermore, the ComASP test kit for cefiderocol minimum-inhibitory concentration (MIC) determination was compared to the EUCAST reference method broth microdilution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cefiderocol resistance rate of Pseudomonas aeruginosa was 1.5% while resistance to the comparator agents ranged from 19.7% to 40.9%. Among both Acinetobacter baumannii and Stenotrophomonas maltophilia isolates the MIC50 value of cefiderocol was six or more log2 steps lower than the ones of the comparator agents. Seven isolates (three Escherichia coli, one Klebsiella pneumoniae, one P. aeruginosa and two A. baumannii) revealed cefiderocol MICs &amp;gt; 2\u2005mg\/L. While different beta-lactamase genes were detected in these isolates, they were most probably not solely responsible for cefiderocol resistance. MICs produced by ComASP test kits were comparable to the results of broth microdilution in E. coli, K. pneumoniae, P. aeruginosa and S. maltophilia (categorical agreement &amp;gt; 95%; essential agreement &amp;gt; 91%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, cefiderocol activity against P. aeruginosa, A. baumannii and S. maltophilia was higher compared to the other agents tested.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jacamr\/dlag103","type":"journal-article","created":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T11:35:40Z","timestamp":1780227340000},"source":"Crossref","is-referenced-by-count":1,"title":["Update on the comparative\n                    <i>in vitro<\/i>\n                    activity of cefiderocol and four \u03b2-lactam\u2013\u03b2-lactamase-inhibitor combinations against clinically important Gram-negative pathogens"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9756-7385","authenticated-orcid":false,"given":"E","family":"Wohlfarth","sequence":"first","affiliation":[{"name":"Antiinfectives Intelligence GmbH , Gottfried-Hagen-Str. 60-62, Cologne 51105 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Deuchert","sequence":"additional","affiliation":[{"name":"Antiinfectives Intelligence GmbH , Gottfried-Hagen-Str. 60-62, Cologne 51105 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8662-218X","authenticated-orcid":false,"given":"S G","family":"Gatermann","sequence":"additional","affiliation":[{"name":"German National Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Ruhr-University Bochum , Universit\u00e4tsstr. 150, Bochum 44801 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8677-9454","authenticated-orcid":false,"given":"P G","family":"Higgins","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and University Hospital Cologne, Institute for Medical Microbiology, Immunology and Hygiene , Goldenfelsstr. 19-21, Cologne 50935 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Pfeifer","sequence":"additional","affiliation":[{"name":"Institute of Translational Research, CECAD Cluster of Excellence, University of Cologne , Joseph-Stelzmann-Stra\u00dfe 26, Cologne 50931 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6403-5646","authenticated-orcid":false,"given":"N","family":"Pfennigwerth","sequence":"additional","affiliation":[{"name":"German National Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Ruhr-University Bochum , Universit\u00e4tsstr. 150, Bochum 44801 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7732-4762","authenticated-orcid":false,"given":"H","family":"Seifert","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and University Hospital Cologne, Institute for Medical Microbiology, Immunology and Hygiene , Goldenfelsstr. 19-21, Cologne 50935 ,","place":["Germany"]},{"name":"Institute of Translational Research, CECAD Cluster of Excellence, University of Cologne , Joseph-Stelzmann-Stra\u00dfe 26, Cologne 50931 ,","place":["Germany"]},{"name":"German Centre for Infection Research, partner Site Bonn-Cologne ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Werner","sequence":"additional","affiliation":[{"name":"Robert Koch-Institute, FG13 Nosocomial Pathogens and Antibiotic Resistances , Burgstr. 37, Wernigerode 38855 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Study Group \u2018Antimicrobial Resistance\u2019 of the Paul-Ehrlich-Society for Infection Therapy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"H\u00f6rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Hischebeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Holfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Eigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Gatermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Stapmanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Diefenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Knaust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Kniehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Bohnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Kolbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Imirzalioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Mellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Idelevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Podbielski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Devid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter-Michael","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Scharrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Jantsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Mattwich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Stefanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Joss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Wei\u00dfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Herbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wichelhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Ziesing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Reineke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"2026063005515249000_dlag103-B1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","article-title":"Antibiotics: past, present and future","volume":"51","author":"Hutchings","year":"2019","journal-title":"Curr Opin Microbiol"},{"key":"2026063005515249000_dlag103-B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/antibiotics12010073","article-title":"State of knowledge on the acquisition, diversity, interspecies attribution and spread of antimicrobial resistance between humans, animals and the environment: a systematic review","volume":"12","author":"Meier","year":"2022","journal-title":"Antibiotics"},{"key":"2026063005515249000_dlag103-B3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/1040841X.2012.691870","article-title":"Extended spectrum \u03b2-lactamases, carbapenemases and mobile genetic elements responsible for antibiotics resistance in Gram-negative bacteria","volume":"39","author":"El Salabi","year":"2013","journal-title":"Crit Rev Microbiol"},{"key":"2026063005515249000_dlag103-B4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/ph15040476","article-title":"\u03b2-Lactam antibiotics and \u03b2-lactamase enzymes inhibitors, part 2: our limited resources","volume":"15","author":"Alfei","year":"2022","journal-title":"Pharmaceuticals"},{"key":"2026063005515249000_dlag103-B5","doi-asserted-by":"publisher","first-page":"7396","DOI":"10.1128\/AAC.01405-16","article-title":"Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa","volume":"60","author":"Ito","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2026063005515249000_dlag103-B6","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s15010-020-01520-6","article-title":"Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems","volume":"48","author":"Karakonstantis","year":"2020","journal-title":"Infection"},{"key":"2026063005515249000_dlag103-B7","doi-asserted-by":"publisher","first-page":"S538","DOI":"10.1093\/cid\/ciz826","article-title":"Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin","volume":"69","author":"Sato","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026063005515249000_dlag103-B8","doi-asserted-by":"publisher","first-page":"106128","DOI":"10.1016\/j.ijantimicag.2020.106128","article-title":"In vitro activity of cefiderocol against aerobic Gram-negative bacterial pathogens from Germany","volume":"56","author":"Kresken","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2026063005515249000_dlag103-B9","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/antibiotics12050864","article-title":"In vitro activity of cefiderocol against clinical gram-negative isolates originating from Germany in 2016\/17","volume":"12","author":"Wohlfarth","year":"2023","journal-title":"Antibiotics"},{"key":"2026063005515249000_dlag103-B10","volume-title":"Susceptibility Testing of Infectious Agents and Evaluation of Performance of Antimicrobial Susceptibility Test Devices\u2014Part 1: Broth Micro-Dilution Reference Method for Testing the in Vitro Activity of Antimicrobial Agents Against Rapidly Growing Aerobic bacteria Involved in Infectious Diseases","author":"International Organization for Standardization","year":"2019"},{"key":"2026063005515249000_dlag103-B11","author":"European Committee on Antimicrobial Susceptibility Testing"},{"key":"2026063005515249000_dlag103-B12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.diagmicrobio.2019.03.003","article-title":"Reproducibility of broth microdilution MICs for the novel siderophore cephalosporin, cefiderocol, determined using iron-depleted cation-adjusted Mueller-Hinton broth","volume":"94","author":"Hackel","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026063005515249000_dlag103-B13","volume-title":"Clinical Laboratory Testing and in Vitro Diagnostic Test Systems\u2014Susceptibility Testing of Infectious Agents and Evaluation of Performance of Antimicrobial Susceptibility Test Devices\u2014Part 2: Evaluation of Performance of Antimicrobial Susceptibility Test Devices Against Reference Broth Microdilution","author":"International Organization for Standardization","year":"2021"},{"key":"2026063005515249000_dlag103-B14","volume-title":"Ten Threats to Global Health in 2019","author":"World Health Organization","year":"2019"},{"key":"2026063005515249000_dlag103-B15","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2147\/IDR.S234610","article-title":"Antimicrobial resistance: implications and costs","volume":"12","author":"Dadgostar","year":"2019","journal-title":"Infect Drug Resist"},{"key":"2026063005515249000_dlag103-B16","volume-title":"Antimicrobial Resistance Surveillance in Europe 2023\u20132021 Data","author":"European Centre for Disease Prevention and Control, & World Health Organization Regional Office for Europe","year":"2023"},{"key":"2026063005515249000_dlag103-B17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11908-019-0690-9","article-title":"Recognizing and overcoming resistance to new Beta-lactam\/Beta-lactamase inhibitor combinations","volume":"21","author":"Ho","year":"2019","journal-title":"Curr Infect Dis Rep"},{"key":"2026063005515249000_dlag103-B18","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01649-20","article-title":"Cefiderocol antimicrobial susceptibility testing against multidrug-resistant gram-negative bacilli: a comparison of disk diffusion to broth microdilution","volume":"59","author":"Paul Morris","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2026063005515249000_dlag103-B19","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00951-20","article-title":"Cefiderocol antimicrobial susceptibility testing considerations: the achilles\u2019 heel of the trojan horse?","volume":"59","author":"Simner","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2026063005515249000_dlag103-B20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3390\/antibiotics12030604","article-title":"Disc diffusion and ComASP\u00ae cefiderocol microdilution panel to overcome the challenge of cefiderocol susceptibility testing in clinical laboratory routine","volume":"12","author":"Bianco","year":"2023","journal-title":"Antibiotics"},{"key":"2026063005515249000_dlag103-B21","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae169","article-title":"Real-world performance of susceptibility testing for cefiderocol: insights from a prospective multicentre study on Gram-negative bacteria","volume":"6","author":"Irigoyen-Von-Sierakowski","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"2026063005515249000_dlag103-B22","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1093\/jac\/dkac221","article-title":"Evolution of \u03b2-lactamase-mediated cefiderocol resistance","volume":"77","author":"Fr\u00f6hlich","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2026063005515249000_dlag103-B23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/ajcp\/aqab115","article-title":"Case report and genomic analysis of cefiderocol-resistant Escherichia coli clinical isolates","volume":"157","author":"Price","year":"2022","journal-title":"J Clin Pathol"},{"key":"2026063005515249000_dlag103-B24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/jac\/dkad396","article-title":"In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity","volume":"79","author":"Gill","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2026063005515249000_dlag103-B25","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/antibiotics12071172","article-title":"In vitro activity of cefiderocol against a global collection of carbapenem-resistant Acinetobacter baumannii isolates","volume":"12","author":"Seifert","year":"2023","journal-title":"Antibiotics"},{"key":"2026063005515249000_dlag103-B26","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00828-22","article-title":"Structural basis of PER-1-mediated cefiderocol resistance and synergistic inhibition of PER-1 by cefiderocol in combination with avibactam or durlobactam in Acinetobacter baumannii","volume":"66","author":"Liu","year":"2022","journal-title":"Antimicrob Agents Chemotherapy"},{"key":"2026063005515249000_dlag103-B27","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.2147\/IDR.S392241","article-title":"Resistance to cefiderocol involved expression of PER-1 \u03b2-lactamase and downregulation of iron transporter system in carbapenem-resistant Acinetobacter baumannii","volume":"15","author":"He","year":"2022","journal-title":"Infect Drug Resist"},{"key":"2026063005515249000_dlag103-B28","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1093\/jac\/dkaa117","article-title":"Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia","volume":"75","author":"Delgado-Valverde","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2026063005515249000_dlag103-B29","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00559-20","article-title":"Activity of cefiderocol alone and in combination with levofloxacin, minocycline, polymyxin B, or trimethoprim-sulfamethoxazole against multidrug-resistant Stenotrophomonas maltophilia","volume":"64","author":"Biagi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2026063005515249000_dlag103-B30","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00618-22","article-title":"Efficacy of cefiderocol in experimental Stenotrophomonas maltophilia pneumonia in persistently neutropenic rabbits","volume":"66","author":"Petraitis","year":"2022","journal-title":"Antimicrob Agents Chemother"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/8\/3\/dlag103\/68487060\/dlag103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/8\/3\/dlag103\/68487060\/dlag103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:55:00Z","timestamp":1782816900000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlag103\/8703636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlag103","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,30]]},"article-number":"dlag103"}}